Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biogen Inc (BIIB)

Biogen Inc (BIIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,198,400
  • Shares Outstanding, K 146,452
  • Annual Sales, $ 10,982 M
  • Annual Income, $ 1,556 M
  • 60-Month Beta 0.42
  • Price/Sales 2.72
  • Price/Cash Flow 7.51
  • Price/Book 2.68
Trade BIIB with:

Options Overview Details

View History
  • Implied Volatility 34.42% ( -1.99%)
  • Historical Volatility 38.35%
  • IV Percentile 8%
  • IV Rank 3.66%
  • IV High 120.28% on 06/04/21
  • IV Low 31.16% on 08/12/21
  • Put/Call Vol Ratio 0.34
  • Today's Volume 5,068
  • Volume Avg (30-Day) 2,757
  • Put/Call OI Ratio 0.82
  • Today's Open Interest 108,812
  • Open Int (30-Day) 108,976

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 4.16
  • Number of Estimates 27
  • High Estimate 5.29
  • Low Estimate 3.27
  • Prior Year 5.68
  • Growth Rate Est. (year over year) -26.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
187.16 +10.17%
on 05/09/22
214.77 -3.99%
on 05/03/22
-0.74 (-0.36%)
since 04/27/22
3-Month
187.16 +10.17%
on 05/09/22
225.50 -8.56%
on 04/20/22
-1.18 (-0.57%)
since 02/25/22
52-Week
187.16 +10.17%
on 05/09/22
468.55 -55.99%
on 06/07/21
-61.17 (-22.88%)
since 05/27/21

Most Recent Stories

More News
INmune Bio (INMB) Down on Clinical Hold for Alzheimer's Study

The FDA places clinical hold on INmune Bio's (INMB) IND application to begin a phase II study on the investigational TNF inhibitor, XPro1595, for Alzheimer's disease.

BIIB : 206.20 (+0.97%)
AGLE : 1.5700 (+1.29%)
LPTX : 1.1100 (-7.50%)
INMB : 6.80 (+7.42%)
3 Buy-Rated Biotechs to Buy in May

Despite logistical hurdles, the biotech industry is expected to expand solidly in the coming years on lucrative federal investments and strong demand. Therefore, we think it could be wise to bet on the...

BIIB : 206.20 (+0.97%)
BNTX : 166.96 (+5.57%)
INCY : 77.19 (+1.54%)
3 Healthcare Stocks That Are Too Cheap to Ignore

A rebound could be on the horizon.

MRNA : 147.66 (+8.73%)
TDOC : 35.77 (+6.94%)
BIIB : 206.20 (+0.97%)
How Are Biotech ETFs Reacting to These Q1 Earnings Releases?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

BIIB : 206.20 (+0.97%)
AMGN : 255.26 (+0.87%)
GILD : 64.80 (+0.51%)
IBB : 119.50 (+3.20%)
XBI : 71.09 (+3.83%)
BBH : 151.48 (+3.51%)
Is This Growth Stock Defeated After Collapsing 22% in a Year?

Things haven't been this bad for the company in quite a long time.

BIIB : 206.20 (+0.97%)
The Zacks Analyst Blog Highlights Oracle, Union Pacific, Ford Motor, Biogen and Expedia Group

Oracle, Union Pacific, Ford Motor, Biogen and Expedia Group have been included in this Analyst Blog.

BIIB : 206.20 (+0.97%)
F : 13.63 (+3.89%)
UNP : 222.50 (+0.55%)
EXPE : 130.97 (+0.52%)
ORCL : 72.78 (+1.56%)
Ionis (IONS) Q1 Earnings & Sales Beat Estimates, Stock Rises

Ionis (IONS) incurs a narrower-than-expected loss in Q1. Its sales also come ahead of estimates. Stock moves up in response to the results.

AZN : 67.40 (+1.05%)
NVS : 91.46 (+0.22%)
BIIB : 206.20 (+0.97%)
IONS : 37.63 (+2.67%)
Analyst Upgrades and Research Reports for Oracle, Union Pacific, Ford & Others

Today's Research Daily features new research reports on 16 major stocks, including Oracle Corporation (ORCL), Union Pacific Corporation (UNP), and Ford Motor Company (F).

BIIB : 206.20 (+0.97%)
F : 13.63 (+3.89%)
UNP : 222.50 (+0.55%)
PPG : 130.03 (+2.95%)
EXPE : 130.97 (+0.52%)
ORCL : 72.78 (+1.56%)
Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis

The investigational prescription digital therapeutic uses a combination of sensors, software, and music based on Rhythmic Auditory Stimulation...

BIIB : 206.20 (+0.97%)
Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis

Biogen Inc. (Nasdaq: BIIB) and MedRhythms have entered into a license agreement to develop and commercialize MR-004, an investigational prescription digital therapeutic for the potential treatment of...

BIIB : 206.20 (+0.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Biogen Inc. is one of the world's leading biotechnology companies which focuses on developing innovative therapies for treating serious neurological and neurodegenerative diseases, including its core growth areas of multiple sclerosis (MS) and neuroimmunology, Alzheimer's disease (AD) and dementia, movement...

See More

Key Turning Points

3rd Resistance Point 212.23
2nd Resistance Point 209.80
1st Resistance Point 208.00
Last Price 206.20
1st Support Level 203.77
2nd Support Level 201.33
3rd Support Level 199.53

See More

52-Week High 468.55
Fibonacci 61.8% 361.06
Fibonacci 50% 327.85
Fibonacci 38.2% 294.65
Last Price 206.20
52-Week Low 187.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar